Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Completed 7Recruiting 3Active not recruiting 3Terminated 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Smoking Cessation 2Tobacco Use Disorder 1Tobacco Smoking 1Substance-Related Disorders 1Cigarette Smoking-Related Carcinoma 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Nicotine Replacement Therapy × Clear all
NCT05515354 2026-03-19

MC-NRT

Centre for Addiction and Mental Health

Phase 4 Recruiting
1,200 enrolled

Tobacco Smoking, Tobacco Use Disorder, Smoking Cessation, Substance-Related Disorders

NCT06290869 2026-02-17

TEAL

Georgetown University

Phase 3 Recruiting
1,188 enrolled

Smoking Cessation

NCT06763536 2025-06-22

ARISE

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
1,000 enrolled

Cigarette Smoking-Related Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡